These substances, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess different chemical architectures leading to their varying pharmacological effects. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily detected via its molecular formula – C14H15N6O4·H2SO4 – and characteristic spectral properties observed in techniques such as mass spectrometry and infrared analysis. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor blocker, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for full identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate cancer treatment, can be verified through its particular mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) analytical data, ensuring its correct chemical characterization.
Product: Abacavir Disulfate Sulfate (CAS 188062-50-2) & Related Materials
Explore a extensive catalogue detailing Abacavir Sulfate, identified by CAS number 188062-50-2, and a variety of related compounds. We offering includes various grades to satisfy precise research and manufacturing needs. You'll detailed information including experimental data and stock quantities options. Besides, investigate the lineup of structurally cognate materials that could be ACECLOFENAC 89796-99-6 useful in your current endeavor. The directory is designed to assist efficient acquiring of premium research reagents.
Pharmaceutical Listing: Abarelix and Abirateron Acetate Registry Numbers
For scientists and drug professionals requiring precise drug identification, correct CAS identifiers are vital. Specifically, abarelix, a hormone-releasing hormone antagonist used in managing prostate cancer, is designated the Registry number 65572-21-8. Furthermore, abiraterone acetate, a key treatment in metastatic cancer, carries the CAS identifier 389292-17-3. Careful recording and validation of these Chemical Abstract Service identifiers are imperative to ensure correct substance recognition and subsequent procedures. Such identifiers are freely accessible through different chemical databases. Frequently consult recognized references for the latest data.
Active Components: Abacavir , Abarelix, Abiraterone , CAS Numbers
The determination of key pharmaceutical compounds often relies on accurate chemical references. In particular, this article briefly examines three notable examples: Abacavir Sodium, a drug reverse polymerase inhibitor; Abarelix, a gonadotropin-releasing agonist; and Abiraterone, utilized in tumor treatment. Each molecule is associated with a unique Registry number, offering a consistent method for identifying information and guaranteeing accurate reporting within the research industry. View the respective repositories for complete records and related records.
CAS Number Database: Details for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The extensive Chemical Abstracts Service (CAS) number is an critical resource for chemists and pharmaceutical professionals alike. This section briefly details records pertaining to three important therapeutic compounds: Abacavir Sulfate, a drug used to combat HIV; Abarelix Acetate, a gonadotropin-releasing hormone (GnRH) receptor antagonist employed in therapy; and Abiraterone Acetate, a potent copyright biosynthesis inhibitor administered in the management of metastatic aggressive cancer. Locating the precise CAS identification for each substance allows for unambiguous identification and facilitates accurate literature retrieval. These individual identifiers are necessary for scientific validation and standardized communication across the industry.
Employing Application Programming Interface Substance Data: Item Recognition with CAS Registry Numbers
Accurate compound identification is paramount in the substance industry, and Web API chemical data provides a consistent method. Particularly, CAS numbers act as distinct labels for material entities, enabling effortless association with repositories and platforms. Such methodology also improves information quality but likewise accelerates workflows related to research, acquisition, and compliance submission. Furthermore, retrieving this information via an API promotes efficiency and lessens the potential for manual mistake.